1. Race and socioeconomic status impact diagnosis and clinical outcomes in transthyretin cardiac amyloidosis;Shankar;J Am Coll Cardiol CardioOnc,2024
2. Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey);Maurer;J Am Coll Cardiol,2016
3. Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis;Lane;Circulation,2019
4. Transthyretin V142I genetic variant and cardiac remodeling, injury, and heart failure risk in Black adults;Coniglio;J Am Coll Cardiol HF,2022
5. Racial and genetic differences in presentation of transthyretin amyloid cardiomyopathy with impaired left ventricular function;Martyn;J Am Coll Cardiol HF,2022